AllianceBernstein’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,689,629
Closed -$80.2M 3237
2025
Q3
$80.2M Buy
1,689,629
+153,429
+10% +$7.43M 0.03% 489
2025
Q2
$82M Buy
1,536,200
+284,831
+23% +$12.9M 0.03% 461
2025
Q1
$50.7M Sell
1,251,369
-587,912
-32% -$24.9M 0.02% 584
2024
Q4
$51.2M Sell
1,839,281
-177,807
-9% -$5.38M 0.02% 587
2024
Q3
$57.9M Buy
2,017,088
+109,231
+6% +$2.85M 0.02% 567
2024
Q2
$44.8M Buy
1,907,857
+286,595
+18% +$6.13M 0.02% 626
2024
Q1
$41M Buy
1,621,262
+13,571
+0.8% +$326K 0.01% 660
2023
Q4
$37.5M Buy
1,607,691
+325,981
+25% +$6.43M 0.01% 675
2023
Q3
$64.8M Buy
1,281,710
+1,161,305
+964% +$54.1M 0.03% 486
2023
Q2
$5.62M Buy
120,405
+46,515
+63% +$2.13M ﹤0.01% 1386
2023
Q1
$2.83M Buy
73,890
+39,310
+114% +$1.75M ﹤0.01% 1682
2022
Q4
$1.89M Buy
34,580
+10,052
+41% +$431K ﹤0.01% 1950
2022
Q3
$835K Buy
24,528
+3,128
+15% +$47.9K ﹤0.01% 2390
2022
Q2
$202K Buy
21,400
+5,400
+34% +$56.3K ﹤0.01% 3023
2022
Q1
$227K Hold
16,000
﹤0.01% 2961
2021
Q4
$338K Hold
16,000
﹤0.01% 2909
2021
Q3
$358K Sell
16,000
-2,900
-15% -$65.6K ﹤0.01% 2895
2021
Q2
$469K Buy
18,900
+4,200
+29% +$118K ﹤0.01% 2838
2021
Q1
$426K Sell
14,700
-2,300
-14% -$69.6K ﹤0.01% 2733
2020
Q4
$439K Sell
17,000
-1,700
-9% -$47.3K ﹤0.01% 2652
2020
Q3
$576K Sell
18,700
-3,400
-15% -$119K ﹤0.01% 2459
2020
Q2
$551K Buy
22,100
+7,900
+56% +$181K ﹤0.01% 2547
2020
Q1
$301K Buy
+14,200
New +$305K ﹤0.01% 2618

Other funds holding AKRO